Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Table 3 Cardiopulmonary ultrasound findings: prevalence and test characteristics

From: Focused cardiopulmonary ultrasound for assessment of dyspnea in a resource-limited setting

CPUS findings Prevalence % Sensitivity % Specificity % Kappa
Pericardial effusion 7.7 (3.8, 14.5) 88.9 (50.7, 99.4) 99.1 (94.2, 100) 0.81*
LVEF <50 % 40.2 (31.3, 49.7) 93.6 (81.4, 98.3) 100 (93.5, 100) 0.98*
MV disease 53.8 (43.2, 64.1) 86.0 (72.6, 93.7) 86.0 (71.4, 94.2) 0.696*
Pleural effusion 25.7 (20.2, 31.9) 83.1 (70.6, 91.1) 100 (97.3, 100) 0.73*
Interstitial synd. 36.3 (30.1, 43.0) 92.7 (84.2, 97.0) 97.9 (93.6, 99.5) 0.49*
  1. Numbers are reported as a percentage (confidence interval)
  2. CPUS cardiopulmonary ultrasound, LVEF left ventricular ejection fraction, MV mitral valve, Interstitial synd Interstitial Syndrome)
  3. p < 0.001